Best African American Response to Asthma Drugs (BARD)

Trial Status: 
Closed

Purpose: 

The purpose of this study is to find the best asthma treatment to add for African American/Black people who have asthma that is not well controlled on a low dose of inhaled steroid. This study will also try to find out if African American/Black adults and children differ in how they respond to the medications used in this study.

Eligibility: 

People 5 years of age and older, who are of African American/Black ancestry may be eligible to join this study. At this time, the University of Arizona is only enrolling participants age 5  years to 11 years. Enrollment for individuals 12 years and older has closed. 

For more information, visit the AsthmaNet web site.

Sponsor:

The National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)

Network:

AsthmaNet Network

Links:

ClinicalTrials.gov

Principal Investigator: Fernando Martinez, MD

Contact Information:

Office: (520) 626-9543

Email: lungresearch@email.arizona.edu

Network: 

AsthmaNet Network

Principal Investigator: 
Research Area: 
Clinical and Population Research